Operating Lease, Right-of-Use Asset of X4 Pharmaceuticals, Inc from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
X4 Pharmaceuticals, Inc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • X4 Pharmaceuticals, Inc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,775,000, a 60% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

X4 Pharmaceuticals, Inc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,775,000 -$2,696,000 -60% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $2,646,000 -$2,226,000 -46% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $3,652,000 -$1,612,000 -31% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $4,065,000 -$1,585,000 -28% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $4,471,000 -$1,583,000 -26% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $4,872,000 -$1,580,000 -24% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $5,264,000 -$1,580,000 -23% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $5,650,000 -$1,579,000 -22% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $6,054,000 -$1,552,000 -20% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $6,452,000 -$1,524,000 -19% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q3
Q1 2023 $6,844,000 -$1,500,000 -18% 31 Mar 2023 10-Q 04 May 2023 2022 Q3
Q4 2022 $7,229,000 -$1,481,000 -17% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $7,606,000 -$1,465,000 -16% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $7,976,000 -$1,454,000 -15% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $8,344,000 -$1,444,000 -15% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $8,710,000 +$750,000 +9.4% 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q3 2021 $9,071,000 +$849,000 +10% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $9,430,000 +$7,786,000 +474% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $9,788,000 +$7,985,000 +443% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $7,960,000 +$6,001,000 +306% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $8,222,000 +$6,112,000 +290% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $1,644,000 -$543,000 -25% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $1,803,000 -$902,000 -33% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $1,959,000 31 Dec 2019 10-K 19 Mar 2021 2020 FY
Q3 2019 $2,110,000 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $2,187,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $2,705,000 31 Mar 2019 10-Q 15 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.